TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9555595

Group type: EXPERIMENTAL
Intervention: Risperidone 8 mg once daily
Number of subjects: 211

Group type: COMPARATOR
Intervention: Risperidone 4 mg twice daily
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 211
Study: 8200551

Group type: EXPERIMENTAL
Intervention: Adrenaline alone (3-10 ml of 1:100,000 adrenaline)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Adrenaline plus ethanolamine oleate (5%)
Number of subjects: 107
Study: 3312133

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (50 mg elemental zinc/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29371262

Group type: EXPERIMENTAL
Intervention: 6-month structured lifestyle programme
Number of subjects: 564

Group type: COMPARATOR
Intervention: Infertility care as usual
Number of subjects: 564
Study: 28557676

Group type: EXPERIMENTAL
Intervention: Intervention based on the Valencia Model of Waking Hypnosis combined with Cognitive‐Behavioral Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study: 26084292

Group type: EXPERIMENTAL
Intervention: PCH (trastuzumab and paclitaxel weekly combined with carboplatin weekly)
Number of subjects: 100

Group type: COMPARATOR
Intervention: PEH (epirubicin every 3 weeks combined with trastuzumab and paclitaxel)
Number of subjects: 100
Study: 24011142

Group type: COMPARATOR
Intervention: Motivational interviewing tailored lifestyle intervention (MINT)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Culturally targeted patient navigation (PN) intervention
Number of subjects: 480
Study: 21943032

Group type: EXPERIMENTAL
Intervention: Docetaxel (DCT) 20 mg/m2/week and continuous fluorouracil (5-FU) 200 mg/m2/day plus concurrent radiotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Docetaxel (DCT) 20 mg/m2/week and cisplatin (CDDP) 20 mg/m2 plus concurrent radiotherapy
Number of subjects: 40
Study: 19047492

Group type: EXPERIMENTAL
Intervention: Nurse-led hospice collaborative; specific details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classroom instruction; specific details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of classroom and hospice experiences; specific details on dosage and duration not available.
Number of subjects: 0
Study: 14712904

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention carried out by outreach visitors
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Costs of the intervention
Number of subjects: 62
Study: 10225493

Group type: EXPERIMENTAL
Intervention: Three-session family intervention
Number of subjects: 428

Group type: COMPARATOR
Intervention: No-intervention control condition
Number of subjects: 428
Study: 7600600

Group type: EXPERIMENTAL
Intervention: Denmark II lyophilized vaccines
Number of subjects: 0
Study: 2223928

Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (m-CPP), 80 mg/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 352417

Group type: EXPERIMENTAL
Intervention: eserine amine oxide
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: pentagastrin
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: histamine
Number of subjects: 14
Study: 30941424

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg intravenously every 2 weeks
Number of subjects: 821

Group type: COMPARATOR
Intervention: Everolimus 10 mg orally once daily
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 821

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 821
Study: 28717929

Group type: EXPERIMENTAL
Intervention: CAS‐based pharmacist‐physician intervention
Number of subjects: 231

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 231
Study: 26536017

Group type: EXPERIMENTAL
Intervention: Dysport
Number of subjects: 34

Group type: COMPARATOR
Intervention: Prosigne
Number of subjects: 34
Study: 23618879

Group type: EXPERIMENTAL
Intervention: Agenda-setting form distributed to patients (77 patients)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Agenda-setting form (intervention group)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (36 patients)
Number of subjects: 113
Study: 21949699

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV delivered via autologous ex vivo transfected dendritic cells (DC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: ALVAC-HIV delivered intramuscularly (i.m.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: ALVAC-HIV delivered intradermally (i.d.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: ALVAC-HIV delivered subcutaneously (s.q.)
Number of subjects: 15
Study: 19526744

Group type: EXPERIMENTAL
Intervention: Nidotherapy enhanced assertive treatment (up to 12 sessions)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Continued assertive outreach care
Number of subjects: 52
Study: 17341178

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodal treatment therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIH Chronic Prostatitis Symptom Index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four-glass test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-glass test
Number of subjects: 0
Study: 16134605

Group type: EXPERIMENTAL
Intervention: S (+) ‐ismer of ibuprofen suppository (one suppository per day for 3 days)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Ibuprofen suppository (one suppository per day for 3 days)
Number of subjects: 163
Study: 11842836

Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg/night
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo 25 mg/night
Number of subjects: 10
Study: 9990417

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% gel applied immediately after washing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adapalene 0.1% gel applied 20-30 min after washing
Number of subjects: 25
Study: 7800211

Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 31

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 31
Study: 3378661

Group type: EXPERIMENTAL
Intervention: Oxaprozin 1200 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac sodium 100 mg/day
Number of subjects: 40
Study: 31169393

Group type: EXPERIMENTAL
Intervention: family CBT
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: child CBT
Number of subjects: 128
Study: 26414279

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (Keep your brain fit!)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 376
Study: 25505221

Group type: EXPERIMENTAL
Intervention: Strategy training (n = 15, 10 sessions as adjunct to usual inpatient rehabilitation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reflective listening (n = 15, same dose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Strategy training
Number of subjects: 30
Study: 23644179

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg)
Number of subjects: 1039

Group type: COMPARATOR
Intervention: Atorvastatin (80 mg)
Number of subjects: 1039
Study: 21326270

Group type: EXPERIMENTAL
Intervention: Strawberry yogurt-based drink supplemented with B. lactis BB-12
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo yogurt drink without B. lactis BB-12
Number of subjects: 172
Study: 19039612

Group type: EXPERIMENTAL
Intervention: Single task (change detection task)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dual task (change detection and PASOT)
Number of subjects: 30
Study: 17218378

Group type: COMPARATOR
Intervention: General anaesthesia (Group G)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anaesthesia with epidural anaesthesia (Group E)
Number of subjects: 0
Study: 15008994

Group type: EXPERIMENTAL
Intervention: Recombinant human TSH (rhTSH) 0.45 mg pretreatment before RAI treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Radioactive iodine (RAI) treatment
Number of subjects: 34
Study: 11319712

Group type: EXPERIMENTAL
Intervention: Vegetable oil-based stanols (2.6 g sitostanol plus 1.2 g campestanol daily)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Wood-based stanols (3.7 g sitostanol plus 0.3 g campestanol daily)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (LEAR-based margarine and shortening)
Number of subjects: 112
Study: 9773392

Group type: EXPERIMENTAL
Intervention: Saquinavir
Number of subjects: 0
Study: 7846220

Group type: EXPERIMENTAL
Intervention: Pharmacological blockades during psychological stress tasks (speech stress, mental arithmetic, reaction-time task)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive indices of sympathetic (preejection period) and parasympathetic (respiratory sinus arrhythmia) control
Number of subjects: 0
Study: 3508327

Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg twice daily for 2 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Naproxen 750 mg twice daily for 2 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Naproxen 375 mg twice daily for 2 weeks (continued from phase I)
Number of subjects: 34
Study: 30324562

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no SDF)
Number of subjects: 120
Study: 28294471

Group type: EXPERIMENTAL
Intervention: Symptom‐Associated Tension (SAT) training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hypoventilation Respiratory Training (HRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Relaxation Skills Training (RST)
Number of subjects: 60
Study: 26262016

Group type: EXPERIMENTAL
Intervention: Mobile app with notifications during 'message-on' periods
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group with no notifications during 'message-off' periods
Number of subjects: 27
Study: 24075465

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 34
Study: 21959572

Group type: EXPERIMENTAL
Intervention: Dermasilk briefs
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cotton briefs (placebo)
Number of subjects: 42
Study: 18248107

Group type: EXPERIMENTAL
Intervention: Walking in place for 3 minutes
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sitting still for 3 minutes (Control)
Number of subjects: 102
Study: 16766483

Group type: EXPERIMENTAL
Intervention: Intense pulsed light with a red filter
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intense pulsed light with a yellow filter
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 810 nm diode laser
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 755 nm alexandrite laser
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control non-treated area
Number of subjects: 10
Study: 14978133

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy (Phleum pratense, Phl P) for 2 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-immunotherapy serum
Number of subjects: 0
Study: 10768243

Group type: EXPERIMENTAL
Intervention: HP-eradication therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Persistent HP-positive patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Successful retherapy for persistent HP-positive patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patients with gastroesophageal reflux disease
Number of subjects: 20
Study: 9351692

Group type: EXPERIMENTAL
Intervention: CORTEX X1
Number of subjects: 15
Study: 8222742

Group type: EXPERIMENTAL
Intervention: Controlled-release metoclopramide ('Gastrobid Continus' tablets) 15 mg given twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal-release metoclopramide ('Maxolon') 10 mg given 4-times daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Controlled-release metoclopramide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal-release metoclopramide
Number of subjects: 20
Study: 3544647

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 40
Study: 29471076

Group type: EXPERIMENTAL
Intervention: Morning energy distribution (50% kcal at breakfast, 30% at lunch, 20% at dinner)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Evening energy distribution (20% kcal at breakfast, 30% at lunch, 50% at dinner)
Number of subjects: 8
Study: 30351770

Group type: EXPERIMENTAL
Intervention: Cryotherapy during AVF puncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: No cryotherapy (Control)
Number of subjects: 30
Study: 25502137

Group type: EXPERIMENTAL
Intervention: High-fidelity mannequins
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mid-fidelity mannequins
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low-fidelity mannequins
Number of subjects: 54
Study: 22788576

Group type: EXPERIMENTAL
Intervention: Authentic acupuncture
Number of subjects: 204

Group type: COMPARATOR
Intervention: Sham acupuncture (control)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Both groups (Authentic and Sham acupuncture)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Authentic acupuncture with low-calorie diet
Number of subjects: 204
Study: 20015104

Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 90 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 60 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 30 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 32
Study: 18298359

Group type: EXPERIMENTAL
Intervention: Walking on a treadmill at 60% heart rate reserve
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Walking on a treadmill at increasing intensities
Number of subjects: 18
Study: 16209675

Group type: EXPERIMENTAL
Intervention: Merocel
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: RapidRhino
Number of subjects: 52
Study: 12620168

Group type: EXPERIMENTAL
Intervention: Diuretics (single or combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no diuretics)
Number of subjects: 0
Study: 10776741

Group type: EXPERIMENTAL
Intervention: Aspirin 160 mg daily
Number of subjects: 17444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17444
Study: 8849769

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening
Number of subjects: 0
Study: 1359319

Group type: EXPERIMENTAL
Intervention: FK‐224 (4 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FK‐224
Number of subjects: 10
Study: 3925929

Group type: EXPERIMENTAL
Intervention: Sodium valproate (600 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Carbamazepine (100 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Phenytoin (1500-2000 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Carbamazepine (800 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 5
Study: 31517976

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 29330573

Group type: COMPARATOR
Intervention: Placebo (430 mg olive oil/day)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Low TT (430 mg TT/day, 70% purity)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: High TT (860 mg TT/day, 70% purity)
Number of subjects: 89
Study: 26739235

Group type: EXPERIMENTAL
Intervention: Mini-tablets (MTs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Orally disintegrating mini-tablet (ODMT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional tablet (CT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional orally disintegrating tablet (ODT)
Number of subjects: 18
Study: 25365893

Group type: EXPERIMENTAL
Intervention: Parent manipulation (performed at least 20 times per day and stimulation of the foot at least 100 times per day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Parent manipulation
Number of subjects: 92

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study: 22479925

Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 382

Group type: COMPARATOR
Intervention: Glucantime (5 days of intralesional administration)
Number of subjects: 382
Study: 20229333

Group type: EXPERIMENTAL
Intervention: Tai chi Qigong (TCQ) program, consisting of two 60‐min sessions each week for 3 months
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Exercise group (breathing techniques combined with walking)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 206
Study: 17161911

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT) followed by interferon-alpha
Number of subjects: 6

Group type: COMPARATOR
Intervention: Interferon-alpha only
Number of subjects: 6
Study: 15886836

Group type: EXPERIMENTAL
Intervention: Fluor Protector and temporary crown
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Green Or and temporary crown
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (only temporary crown)
Number of subjects: 118
Study: 12119306

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for bulimia nervosa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined pharmacotherapy and short-term psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized reporting practices
Number of subjects: 0
Study: 9717330

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate for 24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clindamycin plus gentamicin for 24 hours
Number of subjects: 0
Study: 8023058

Group type: EXPERIMENTAL
Intervention: Beta-carotene levels in patients (0.36 microgram/g biopsy)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol levels in patients (237.5 micrograms/g biopsy)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Vitamin C supplement consumption
Number of subjects: 131
Study: 2455151

Group type: EXPERIMENTAL
Intervention: Verapamil SR (to 240 mg b.i.d.)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Metoprolol (to 100 mg b.i.d.)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 35
Study: 29715073

Group type: EXPERIMENTAL
Intervention: GLoBE intervention (12-week exercise program)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham exercise (12-week exercise program)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Both GLoBE and sham exercise programs
Number of subjects: 94
Study: 27532880

Group type: EXPERIMENTAL
Intervention: MusicGlove therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional tabletop exercises
Number of subjects: 17
Study: 24166065

Group type: EXPERIMENTAL
Intervention: IMT+RYGB
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: IMT+SG
Number of subjects: 53

Group type: COMPARATOR
Intervention: IMT
Number of subjects: 53
Study: 23325911

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) intervention delivered by a nurse therapist, up to 12 sessions.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waiting list control condition with standard medical care (SMC).
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) intervention.
Number of subjects: 44
Study: 21523723

Group type: EXPERIMENTAL
Intervention: Dasatinib (administered orally or via percutaneous feeding gastrostomy)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dasatinib (administered via percutaneous feeding gastrostomy)
Number of subjects: 15
Study: 19907042

Group type: EXPERIMENTAL
Intervention: Revascularization plus medical therapy
Number of subjects: 806

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 806
Study: 16951015

Group type: EXPERIMENTAL
Intervention: Topical retinoid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (topical retinoid + antimicrobial agent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical retinoids (maintenance therapy)
Number of subjects: 0
Study: 15234416

Group type: EXPERIMENTAL
Intervention: Tedisamil 0.4 mg/kg
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Tedisamil 0.6 mg/kg
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 11296434

Group type: EXPERIMENTAL
Intervention: Intra-articular lidocaine (Group I, n = 10)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intra-bursal lidocaine (Group II, n = 11)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No lidocaine (Group III, n = 10)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No lidocaine (Group IV, n = 10)
Number of subjects: 41
Study: 9377539

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (10 mg doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 12
Study: 8330468

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 28
Study: 6383055

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 139

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 139
Study: 30977770

Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg/day or 75 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 26899588

Group type: EXPERIMENTAL
Intervention: Early medication change (EMC) strategy: venlafaxine XR for study days 15‐56; lithium augmentation for days 29‐56 if sustained non‐improvement on day 28.
Number of subjects: 192

Group type: COMPARATOR
Intervention: Treatment as usual (TAU): continuation of escitalopram; non-responders on day 28 switched to venlafaxine XR for four weeks (days 29‐56).
Number of subjects: 192
Study: 24548534

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up phone calls over six months.
Number of subjects: 256

Group type: COMPARATOR
Intervention: Introductory educational session only (Control group).
Number of subjects: 256
Study: 23043818

Group type: EXPERIMENTAL
Intervention: Robot-aided walking in a Lokomat robotic trainer
Number of subjects: 8